* | Page 1 | Search Results | Emerging Technologies and Data Science

1-20 of 23 Search Results for

*

Sort by

Sort Order Select

Journal Articles

A melanoma brain metastasis CTC signature and CTC:B cell clusters associate with secondary liver metastasis: a melanoma brain-liver metastasis axis

Tetiana Y Bowley, Mireya C Ortiz, Irina V Lagutina, Mara P. Steinkamp, Bridget N. Fahy, Bernard Tawfik, Moises Harari-Turquie, Dario Marchetti

Cancer Research Communications (2025)

https://doi.org/10.1158/2767-9764.CRC-24-0498

Published: 20 January 2025

View article titled, A melanoma brain metastasis CTC signature and CTC:B cell clusters associate with secondary liver metastasis: a melanoma brain-liver metastasis axis

Includes: Supplementary data

Journal Articles

Loss of NF1 accelerates uveal and intra-dermal melanoma tumorigenesis and oncogenic GNAQ transforms Schwann cells

Anne Nathalie Longakit, Oscar Urtatiz, Amy Luty, Christina Zhang, Chloe Hess, Alyssa Yoo, Hannah Bourget, Catherine D Van Raamsdonk

Cancer Research Communications (2025)

https://doi.org/10.1158/2767-9764.CRC-24-0386

Published: 13 January 2025

View article titled, Loss of NF1 accelerates uveal and intra-dermal melanoma tumorigenesis and oncogenic GNAQ transforms Schwann cells

Includes: Supplementary data

Journal Articles

Epithelial Expressed B7-H4 Drives Differential Immunotherapy Response in Murine and Human Breast Cancer

Cancer Research Communications (2024) 4 (4): 1120–1134.

https://doi.org/10.1158/2767-9764.CRC-23-0468

Published: 24 April 2024

View article titled, Epithelial Expressed B7-H4 Drives Differential Immunotherapy Response in Murine and Human Breast Cancer

Includes: Supplementary data

Journal Articles

Overcoming Xenoantigen Immunity to Enable Cellular Tracking and Gene Regulation with Immune-competent “NoGlow” Mice

Timothy N. Trotter, Andrea Wilson, Jason McBane, Carina E. Dagotto, Xiao-Yi Yang, Jun-Ping Wei, Gangjun Lei, Hannah Thrash, Joshua C. Snyder, Herbert Kim Lyerly, Zachary C. Hartman

Cancer Research Communications (2024) 4 (4): 1050–1062.

https://doi.org/10.1158/2767-9764.CRC-24-0062

Published: 09 April 2024

View article titled, Overcoming Xenoantigen Immunity to Enable Cellular Tracking and Gene Regulation with Immune-competent “NoGlow” Mice

Includes: Supplementary data

Journal Articles

Cancer-associated Fibroblast–specific Expression of the Matricellular Protein CCN1 Coordinates Neovascularization and Stroma Deposition in Melanoma Metastasis

James Hutchenreuther, John Nguyen, Katherine Quesnel, Krista M. Vincent, Louis Petitjean, Sophia Bourgeois, Mark Boyd, George Bou-Gharios, Lynne-Marie Postovit, Andrew Leask

Cancer Research Communications (2024) 4 (2): 556–570.

https://doi.org/10.1158/2767-9764.CRC-23-0571

Published: 27 February 2024

View article titled, Cancer-associated Fibroblast–specific Expression of the Matricellular Protein CCN1 Coordinates Neovascularization and Stroma Deposition in Melanoma Metastasis

Includes: Multimedia, Supplementary data

Journal Articles

Dietary Folate and Cofactors Accelerate Age-dependent p16 Epimutation to Promote Intestinal Tumorigenesis

Li Yang, Robert C. Peery, Leah M. Farmer, Xia Gao, Yiqun Zhang, Chad J. Creighton, Lanjing Zhang, Lanlan Shen

Cancer Research Communications (2024) 4 (1): 164–169.

https://doi.org/10.1158/2767-9764.CRC-23-0356

Published: 19 January 2024

View article titled, Dietary Folate and Cofactors Accelerate Age-dependent p16 Epimutation to Promote Intestinal Tumorigenesis

Includes: Supplementary data

Journal Articles

Single-cell Profiling Uncovers a Muc4-Expressing Metaplastic Gastric Cell Type Sustained by Helicobacter pylori-driven Inflammation

Valerie P. O'Brien, Yuqi Kang, Meera K. Shenoy, Greg Finak, William C. Young, Julien Dubrulle, Lisa Koch, Armando E. Rodriguez Martinez, Jeffery Williams, Elizabeth Donato, Surinder K. Batra, Cecilia C.S. Yeung, William M. Grady, Meghan A. Koch, Raphael Gottardo, Nina R. Salama

Cancer Research Communications (2023) 3 (9): 1756–1769.

https://doi.org/10.1158/2767-9764.CRC-23-0142

Published: 05 September 2023

View article titled, Single-cell Profiling Uncovers a Muc4-Expressing Metaplastic Gastric Cell Type Sustained by Helicobacter pylori-driven Inflammation

Includes: Supplementary data

Journal Articles

Dual Blockade of EP2 and EP4 Signaling is Required for Optimal Immune Activation and Antitumor Activity Against Prostaglandin-Expressing Tumors

Brian J. Francica, Anja Holtz, Justine Lopez, David Freund, Austin Chen, Dingzhi Wang, David Powell, Franciele Kipper, Dipak Panigrahy, Raymond N. Dubois, Chan C. Whiting, Peppi Prasit, Thomas W. Dubensky

Cancer Research Communications (2023) 3 (8): 1486–1500.

https://doi.org/10.1158/2767-9764.CRC-23-0249

Published: 08 August 2023

View article titled, Dual Blockade of EP2 and EP4 Signaling is Required for Optimal Immune Activation and Antitumor Activity Against Prostaglandin-Expressing Tumors

Includes: Supplementary data

Journal Articles

Development of an Anti-canine PD-L1 Antibody and Caninized PD-L1 Mouse Model as Translational Research Tools for the Study of Immunotherapy in Humans

Wonkyung Oh, Alyssa Min Jung Kim, Deepika Dhawan, Perry M. Kirkham, Raluca Ostafe, Jackeline Franco, Uma K. Aryal, Robert H. Carnahan, Valery Patsekin, J. Paul Robinson, Deborah W. Knapp, Seung-Oe Lim

Cancer Research Communications (2023) 3 (5): 860–873.

https://doi.org/10.1158/2767-9764.CRC-22-0468

Published: 15 May 2023

View article titled, Development of an Anti-canine PD-L1 Antibody and Caninized PD-L1 Mouse Model as Translational Research Tools for the Study of Immunotherapy in Humans

Includes: Supplementary data

Journal Articles

Uncovering the Protective Neurologic Mechanisms of Hypofractionated FLASH Radiotherapy

Yasaman Alaghband, Barrett D. Allen, Eniko A. Kramár, Richard Zhang, Olivia G.G. Drayson, Ning Ru, Benoit Petit, Aymeric Almeida, Ngoc-Lien Doan, Marcelo A. Wood, Janet E. Baulch, Paola Ballesteros-Zebadua, Marie-Catherine Vozenin, Charles L. Limoli

Cancer Research Communications (2023) 3 (4): 725–737.

https://doi.org/10.1158/2767-9764.CRC-23-0117

Published: 27 April 2023

View article titled, Uncovering the Protective Neurologic Mechanisms of Hypofractionated FLASH Radiotherapy

Journal Articles

IOA-244 is a Non–ATP-competitive, Highly Selective, Tolerable PI3K Delta Inhibitor That Targets Solid Tumors and Breaks Immune Tolerance

Zoë Johnson, Chiara Tarantelli, Elisa Civanelli, Luciano Cascione, Filippo Spriano, Amy Fraser, Pritom Shah, Tyzoon Nomanbhoy, Sara Napoli, Andrea Rinaldi, Karolina Niewola-Staszkowska, Michael Lahn, Dominique Perrin, Mathias Wenes, Denis Migliorini, Francesco Bertoni, Lars van der Veen, Giusy Di Conza

Cancer Research Communications (2023) 3 (4): 576–591.

https://doi.org/10.1158/2767-9764.CRC-22-0477

Published: 14 April 2023

View article titled, IOA-244 is a Non–ATP-competitive, Highly Selective, Tolerable PI3K Delta Inhibitor That Targets Solid Tumors and Breaks Immune Tolerance

Includes: Supplementary data

Journal Articles

Plexin-B1 Mutation Drives Metastasis in Prostate Cancer Mouse Models

Boris Shorning, Neil Trent, David F. Griffiths, Thomas Worzfeld, Stefan Offermanns, Matthew J. Smalley, Magali Williamson

Cancer Research Communications (2023) 3 (3): 444–458.

https://doi.org/10.1158/2767-9764.CRC-22-0480

Published: 16 March 2023

View article titled, Plexin-B1 Mutation Drives Metastasis in Prostate Cancer Mouse Models

Includes: Supplementary data

Journal Articles

Mouse Stromal Cells Confound Proteomic Characterization and Quantification of Xenograft Models

Zhaomei Shi, Binchen Mao, Xiaobo Chen, Piliang Hao, Sheng Guo

Cancer Research Communications (2023) 3 (2): 202–214.

https://doi.org/10.1158/2767-9764.CRC-22-0431

Published: 06 February 2023

View article titled, Mouse Stromal Cells Confound Proteomic Characterization and Quantification of Xenograft Models

Includes: Supplementary data

Journal Articles

On the Choice of Longitudinal Models for the Analysis of Antitumor Efficacy in Mouse Clinical Trials of Patient-derived Xenograft Models

Hélène Savel, Sandrine Barbier, Cécile Proust-Lima, Virginie Rondeau, Rodolphe Thiébaut, Florence Meyer-Losic, Laura Richert

Cancer Research Communications (2023) 3 (1): 140–147.

https://doi.org/10.1158/2767-9764.CRC-22-0238

Published: 26 January 2023

View article titled, On the Choice of Longitudinal Models for the Analysis of Antitumor Efficacy in Mouse Clinical Trials of Patient-derived Xenograft Models

Includes: Supplementary data

Journal Articles

Inactivation of Notch4 Attenuated Pancreatic Tumorigenesis in Mice

Kiyoshi Saeki, Wanglong Qiu, Richard A. Friedman, Samuel Pan, Jordan Lu, Shu Ichimiya, Iok In Christine Chio, Carrie J. Shawber, Jan Kitajewski, Jianhua Hu, Gloria H. Su

Cancer Research Communications (2022) 2 (12): 1601–1616.

https://doi.org/10.1158/2767-9764.CRC-22-0106

Published: 12 December 2022

View article titled, Inactivation of Notch4 Attenuated Pancreatic Tumorigenesis in Mice

Includes: Supplementary data

Journal Articles

The RPL/RPS Gene Signature of Melanoma CTCs Associates with Brain Metastasis

Tetiana Y. Bowley, Irina V. Lagutina, Carol Francis, Sinduja Sivakumar, Reed G. Selwyn, Erik Taylor, Yan Guo, Bridget N. Fahy, Bernard Tawfik, Dario Marchetti

Cancer Research Communications (2022) 2 (11): 1436–1448.

https://doi.org/10.1158/2767-9764.CRC-22-0337

Published: 16 November 2022

View article titled, The RPL/RPS Gene Signature of Melanoma CTCs Associates with Brain Metastasis

Includes: Supplementary data

Journal Articles

Tumor Cell–Autonomous SHP2 Contributes to Immune Suppression in Metastatic Breast Cancer

Hao Chen, Gregory M. Cresswell, Sarah Libring, Mitchell G. Ayers, Jinmin Miao, Zhong-Yin Zhang, Luis Solorio, Timothy L. Ratliff, Michael K. Wendt

Cancer Research Communications (2022) 2 (10): 1104–1118.

https://doi.org/10.1158/2767-9764.CRC-22-0117

Published: 03 October 2022

View article titled, Tumor Cell–Autonomous SHP2 Contributes to Immune Suppression in Metastatic Breast Cancer

Includes: Supplementary data

Journal Articles

A Ketogenic Diet in Combination with Gemcitabine Increases Survival in Pancreatic Cancer KPC Mice

Natalia E. Cortez, Cecilia Rodriguez Lanzi, Brian V. Hong, Jihao Xu, Fangyi Wang, Shuai Chen, Jon J. Ramsey, Matthew G. Pontifex, Michael Müller, David Vauzour, Payam Vahmani, Chang-il Hwang, Karen Matsukuma, Gerardo G. Mackenzie

Cancer Research Communications (2022) 2 (9): 951–965.

https://doi.org/10.1158/2767-9764.CRC-22-0256

Published: 08 September 2022

View article titled, A Ketogenic Diet in Combination with Gemcitabine Increases Survival in Pancreatic Cancer KPC Mice

Includes: Supplementary data

Journal Articles

The Combination of Radiotherapy and Complement C3a Inhibition Potentiates Natural Killer cell Functions Against Pancreatic Cancer

Quaovi H. Sodji, Dhanya K. Nambiar, Vignesh Viswanathan, Rie von Eyben, Deana Colburg, Michael S. Binkley, Caiyun G. Li, Monica M. Olcina, Daniel T. Chang, Quynh-Thu Le, Amato J. Giaccia

Cancer Research Communications (2022) 2 (7): 725–738.

https://doi.org/10.1158/2767-9764.CRC-22-0069

Published: 27 July 2022

View article titled, The Combination of Radiotherapy and Complement C3a Inhibition Potentiates Natural Killer cell Functions Against Pancreatic Cancer

Includes: Supplementary data

Journal Articles

Evaluation of the DLL3-targeting Antibody–Drug Conjugate Rovalpituzumab Tesirine in Preclinical Models of Neuroblastoma

Kateryna Krytska, Colleen E. Casey, Jennifer Pogoriler, Daniel Martinez, Komal S. Rathi, Alvin Farrel, Esther R. Berko, Matthew Tsang, Renata R. Sano, Nathan Kendsersky, Stephen W. Erickson, Beverly A. Teicher, Kumiko Isse, Laura Saunders, Malcolm A. Smith, John M. Maris, Yael P. Mossé

Cancer Research Communications (2022) 2 (7): 616–623.

https://doi.org/10.1158/2767-9764.CRC-22-0137

Published: 11 July 2022

View article titled, Evaluation of the DLL3-targeting Antibody–Drug Conjugate Rovalpituzumab Tesirine in Preclinical Models of Neuroblastoma

Includes: Supplementary data

NARROW

*

A melanoma brain metastasis CTC signature and CTC:B cell clusters associate with secondary liver metastasis: a melanoma brain-liver metastasis axis

Loss of NF1 accelerates uveal and intra-dermal melanoma tumorigenesis and oncogenic GNAQ transforms Schwann cells

Epithelial Expressed B7-H4 Drives Differential Immunotherapy Response in Murine and Human Breast Cancer

Overcoming Xenoantigen Immunity to Enable Cellular Tracking and Gene Regulation with Immune-competent “NoGlow” Mice

Cancer-associated Fibroblast–specific Expression of the Matricellular Protein CCN1 Coordinates Neovascularization and Stroma Deposition in Melanoma Metastasis

Dietary Folate and Cofactors Accelerate Age-dependent p16 Epimutation to Promote Intestinal Tumorigenesis

Single-cell Profiling Uncovers a Muc4-Expressing Metaplastic Gastric Cell Type Sustained by Helicobacter pylori-driven Inflammation

Dual Blockade of EP2 and EP4 Signaling is Required for Optimal Immune Activation and Antitumor Activity Against Prostaglandin-Expressing Tumors

Development of an Anti-canine PD-L1 Antibody and Caninized PD-L1 Mouse Model as Translational Research Tools for the Study of Immunotherapy in Humans

Uncovering the Protective Neurologic Mechanisms of Hypofractionated FLASH Radiotherapy

IOA-244 is a Non–ATP-competitive, Highly Selective, Tolerable PI3K Delta Inhibitor That Targets Solid Tumors and Breaks Immune Tolerance

Plexin-B1 Mutation Drives Metastasis in Prostate Cancer Mouse Models

Mouse Stromal Cells Confound Proteomic Characterization and Quantification of Xenograft Models

On the Choice of Longitudinal Models for the Analysis of Antitumor Efficacy in Mouse Clinical Trials of Patient-derived Xenograft Models

Inactivation of Notch4 Attenuated Pancreatic Tumorigenesis in Mice

The RPL/RPS Gene Signature of Melanoma CTCs Associates with Brain Metastasis

Tumor Cell–Autonomous SHP2 Contributes to Immune Suppression in Metastatic Breast Cancer

A Ketogenic Diet in Combination with Gemcitabine Increases Survival in Pancreatic Cancer KPC Mice

The Combination of Radiotherapy and Complement C3a Inhibition Potentiates Natural Killer cell Functions Against Pancreatic Cancer

Evaluation of the DLL3-targeting Antibody–Drug Conjugate Rovalpituzumab Tesirine in Preclinical Models of Neuroblastoma

AACR Journals

*

AACR Journals

This Feature Is Available To Subscribers Only